Infinity Pharmaceuticals | INFI - Trade Creditors


Infinity Pharmaceuticals reported $1.5M in Trade Creditors for its fiscal quarter ending in June of 2023.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Alterity Therapeutics Limited AUD 1.07M 203.72K Dec/2025
Amgen USD 20.89B 1.25B Dec/2025
AstraZeneca USD 25.28B 252M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Cipla INR 30.35B 1.98B Sep/2025
Clal Biotechnology ILS 21.05M 1.62M Dec/2021
Compugen USD 2.35M 6.77M Dec/2025
CSL USD 3.17B 290M Dec/2025
Eisai JPY 85.49B 4.76B Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Gilead Sciences USD 808M 226M Sep/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
Grifols EUR 987.75M 47.87M Dec/2025
Incyte USD 1.63B 1.46B Dec/2025
Infinity Pharmaceuticals USD 1.5M 433K Jun/2023
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
J&J USD 11.99B 2.37B Dec/2025
Novartis USD 4.46B 99M Dec/2025
Pfizer USD 5.02B 142M Sep/2025
Plus Therapeutics 5.92M 5.7M Dec/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
TG Therapeutics USD 61.64M 72.38M Sep/2025